Tatva Chintan Pharma Chem Ltd

Tatva Chintan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tatva Chintan Pharma Chem Ltd

₹ 704 -0.13%
02 May - close price
tatvachintan.com BSE: 543321 NSE: TATVA
About

Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals[1]

Key Points

Product Portfolio
The company has a portfolio of 214 products divided into 4 categories: [1]

Website BSE NSE
  • Market Cap ₹ 1,646 Cr.
  • Current Price ₹ 704
  • High / Low ₹ 1,284 / 610
  • Stock P/E 4,987
  • Book Value ₹ 308
  • Dividend Yield 0.28 %
  • ROCE 0.24 %
  • ROE 0.05 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 245%

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 7.62% over past five years.
  • Company has a low return on equity of 4.03% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.15%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Allcap BSE Commodities BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
101.88 86.07 84.04 113.54 119.41 106.11 92.57 86.07 93.93 93.81 80.96 84.00 107.65
79.78 72.58 75.11 96.69 104.00 86.50 71.84 73.75 79.73 86.12 76.37 78.35 99.75
Operating Profit 22.10 13.49 8.93 16.85 15.41 19.61 20.73 12.32 14.20 7.69 4.59 5.65 7.90
OPM % 21.69% 15.67% 10.63% 14.84% 12.91% 18.48% 22.39% 14.31% 15.12% 8.20% 5.67% 6.73% 7.34%
1.19 1.88 1.95 1.07 -2.81 1.02 0.76 1.21 4.53 1.42 0.81 0.04 1.30
Interest 1.18 1.06 1.76 2.38 3.18 2.90 3.01 0.38 0.22 0.31 0.17 0.42 0.39
Depreciation 2.15 2.33 2.31 2.38 2.53 6.01 6.78 6.58 6.23 6.66 6.81 6.92 7.26
Profit before tax 19.96 11.98 6.81 13.16 6.89 11.72 11.70 6.57 12.28 2.14 -1.58 -1.65 1.55
Tax % 5.41% 28.96% 22.91% 19.76% -134.40% 29.61% 30.00% 29.07% 32.82% 29.44% -29.75% -29.70% 29.68%
18.89 8.50 5.26 10.56 16.15 8.25 8.20 4.65 8.25 1.51 -1.11 -1.17 1.10
EPS in Rs 8.52 3.83 2.37 4.76 7.29 3.72 3.51 1.99 3.53 0.65 -0.47 -0.50 0.47
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
131 203 254 291 428 403 379 366
110 170 201 226 322 348 312 341
Operating Profit 22 33 53 65 106 55 67 26
OPM % 16% 16% 21% 22% 25% 14% 18% 7%
2 1 1 5 11 2 7 4
Interest 3 4 4 4 5 9 7 1
Depreciation 3 4 5 7 8 10 26 28
Profit before tax 18 26 44 59 103 39 42 0
Tax % 38% 24% 21% 13% 7% -4% 31% 28%
11 20 35 51 96 40 29 0
EPS in Rs 13.74 25.13 43.51 25.57 43.31 18.26 12.55 0.14
Dividend Payout % 0% 0% 0% 20% 5% 11% 16% 709%
Compounded Sales Growth
10 Years: %
5 Years: 8%
3 Years: -5%
TTM: -3%
Compounded Profit Growth
10 Years: %
5 Years: -61%
3 Years: -85%
TTM: -99%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -31%
1 Year: -43%
Return on Equity
10 Years: %
5 Years: 10%
3 Years: 4%
Last Year: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8 8 8 20 22 22 23 23
Reserves 51 72 106 142 447 483 702 698
56 77 91 90 120 170 14 36
29 31 40 58 87 80 75 65
Total Liabilities 145 187 245 310 676 755 815 823
57 67 111 120 160 196 427 531
CWIP 10 6 5 10 51 231 77 22
Investments 1 1 1 1 1 1 11 1
76 114 129 179 464 327 301 269
Total Assets 145 187 245 310 676 755 815 823

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
25 19 20 24 103 24
-40 -21 -197 -101 -121 -65
10 -5 235 38 31 17
Net Cash Flow -6 -6 58 -40 13 -25

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 92 80 73 113 53 82 66 76
Inventory Days 134 98 165 168 299 249 313 228
Days Payable 132 70 88 116 82 52 96 60
Cash Conversion Cycle 94 109 150 166 269 278 282 244
Working Capital Days 105 117 103 152 164 172 167 175
ROCE % 22% 27% 28% 26% 8% 7% 0%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
79.17% 79.17% 79.17% 79.17% 79.17% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02%
3.53% 3.59% 3.74% 3.54% 3.19% 4.40% 4.21% 3.65% 3.37% 3.33% 3.36% 3.30%
10.75% 11.17% 11.52% 11.71% 11.07% 13.78% 13.06% 12.84% 10.64% 6.83% 6.34% 5.46%
6.55% 6.08% 5.58% 5.59% 6.56% 9.79% 10.72% 11.49% 13.97% 17.81% 18.27% 19.21%
No. of Shareholders 84,35876,26771,95870,03770,79974,62874,51973,73073,91279,62379,00978,393

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls